Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FONAR Co. stock logo
FONR
FONAR
$14.13
+1.2%
$12.88
$12.00
$18.68
$87.65M116,407 shs109,275 shs
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$5.13
-2.1%
$5.11
$3.75
$11.00
$296.41M2.031.74 million shs745,119 shs
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$30.39
-1.9%
$30.91
$25.86
$39.08
$275.44M1.3826,132 shs27,384 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$3.99
$4.14
$0.52
$5.92
$262.62M1.92749,035 shs515,955 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FONAR Co. stock logo
FONR
FONAR
+1.22%+9.53%+15.82%-4.38%-8.63%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-2.10%-8.39%+0.59%-18.57%-40.83%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-1.94%-3.52%+0.56%-9.80%+0.36%
Neuronetics, Inc. stock logo
STIM
Neuronetics
0.00%-5.45%-4.77%-3.39%+69.07%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
FONAR Co. stock logo
FONR
FONAR
1.764 of 5 stars
0.05.00.00.01.90.81.9
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
1.3728 of 5 stars
3.51.00.00.02.00.00.6
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1.7976 of 5 stars
3.51.00.00.02.01.70.6
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.4376 of 5 stars
3.32.00.00.00.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FONAR Co. stock logo
FONR
FONAR
0.00
N/AN/AN/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
3.00
Buy$9.5085.19% Upside
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
3.00
Buy$49.5062.88% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.67
Moderate Buy$5.5037.84% Upside

Current Analyst Ratings Breakdown

Latest FONR, NNOX, STIM, and SMTI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/23/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $10.00
5/22/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/15/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$51.00 ➝ $53.00
4/17/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
4/1/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$12.00 ➝ $9.00
3/31/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
3/26/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$46.00 ➝ $46.00
3/26/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$50.00 ➝ $51.00
3/5/2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$5.00 ➝ $8.00
2/25/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$23.00 ➝ $23.00
(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FONAR Co. stock logo
FONR
FONAR
$103.02M0.85$2.96 per share4.78$25.62 per share0.55
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$11.28M26.27N/AN/A$3.55 per share1.45
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$91.57M2.95N/AN/A$5.22 per share5.82
Neuronetics, Inc. stock logo
STIM
Neuronetics
$89.45M2.94N/AN/A$1.18 per share3.38
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FONAR Co. stock logo
FONR
FONAR
$10.57M$1.2512.29N/A7.68%4.94%3.70%N/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$60.78M-$0.90N/AN/AN/A-465.38%-27.63%-24.72%N/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$4.30M-$1.34N/AN/AN/A-10.71%-19.86%-10.91%8/11/2025 (Estimated)
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$30.19M-$1.31N/AN/AN/A-50.09%-141.24%-32.77%8/11/2025 (Estimated)

Latest FONR, NNOX, STIM, and SMTI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/22/2025Q1 2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$0.23-$0.21+$0.02-$0.21$3.98 million$3.00 million
5/15/2025Q3 2025
FONAR Co. stock logo
FONR
FONAR
N/A$0.37N/A$0.37N/AN/A
5/14/2025Q1 2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.31-$0.41-$0.10-$0.41$23.48 million$23.43 million
5/6/2025Q1 2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.13-$0.21-$0.08-$0.21$29.07 million$31.98 million
3/31/2025Q4 2024
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$0.15-$0.23-$0.08-$0.23$3.80 million$3.00 million
3/25/2025Q4 2024
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.19-$0.18+$0.01-$0.18$22.75 million$26.31 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/AN/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/AN/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
FONAR Co. stock logo
FONR
FONAR
N/A
11.24
9.45
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/A
4.64
4.56
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
0.76
2.23
2.02
Neuronetics, Inc. stock logo
STIM
Neuronetics
4.90
3.16
2.87

Institutional Ownership

CompanyInstitutional Ownership
FONAR Co. stock logo
FONR
FONAR
50.64%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
21.49%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
8.10%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%

Insider Ownership

CompanyInsider Ownership
FONAR Co. stock logo
FONR
FONAR
1.55%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
7.74%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
54.10%
Neuronetics, Inc. stock logo
STIM
Neuronetics
8.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
FONAR Co. stock logo
FONR
FONAR
4806.20 million6.19 millionNot Optionable
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
19057.78 million53.31 millionOptionable
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
608.89 million4.01 millionNot Optionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
18065.82 million27.37 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
FONAR stock logo

FONAR NASDAQ:FONR

$14.03 +0.07 (+0.53%)
As of 05/23/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Nano-X Imaging stock logo

Nano-X Imaging NASDAQ:NNOX

$5.13 -0.11 (-2.10%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$5.19 +0.06 (+1.25%)
As of 05/23/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Sanara MedTech stock logo

Sanara MedTech NASDAQ:SMTI

$30.39 -0.60 (-1.94%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$30.36 -0.03 (-0.10%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$3.99 0.00 (0.00%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$4.13 +0.14 (+3.53%)
As of 05/23/2025 06:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.